Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

The crazy part of the story is these two guys started out targeting a marijuana breathalyzer and switched gears to a medical breathalyzer for COVID-19. They have successfully done EGG ZACK LEE what shady leadership of Breathtec/Algernon set out to do in the beginning (Circa 2016). Which is chase after medical diseases. What shareholders got in return is a now flailing about virtual reality repurposed drugs nano cap (under $50M USD market cap) dilution machine stuck in pennyland. The successful startup company will circle back to the marijuana breathalyzer originally targeted. They will likely succeed where as Cannabix remains in prototype mode 8 years and counting. The value of Algernon lies within the value of the mindset of Algernon's management team. A team that has proven itself worth less and less as time rolls on. Algernon's medical device now lies in the hands of Cannabix under another name - in name only. You can bet Team Cobra will do what it can to mimic the successful start up with new stories down the road about detecting anything other than marijuana. The creative storytellers surrounding Team Cobra will surely strike (snake bite) a slew of newbies again and again.

Meet The Founders Of The $2.7 Million Startup Behind The New Covid Breathalyzer

www.forbes.com/sites/katiejennings/2022/04/15/meet-the-founders-of-the-27-million-startup-behind-the-new-covid-breathalyzer/?sh=59cf3cdc5165

Telling stories, diluting shareholders, and running out the clock is job #1 for Team Cobra.

M$